About Technology Issues FAQ

Links

Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.